Pyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione derivatives were investigated as novel small molecule amplifiers of heat shock factor 1 transcriptional activity. Lead optimization led to the discovery of compound 4A-13, which displayed potent HSF1 activity under mild heat stress (EC(50)=2.5microM) and significant cytoprotection in both rotenone (EC(50)=0.23microM) and oxygen-glucose deprivation cell toxicity models (80% protection at 2.5microM).

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2009.05.073DOI Listing

Publication Analysis

Top Keywords

pyrimido[54-e][124]triazine-571h6h-dione derivatives
8
novel small
8
small molecule
8
derivatives novel
4
molecule chaperone
4
chaperone amplifiers
4
amplifiers pyrimido[54-e][124]triazine-571h6h-dione
4
derivatives investigated
4
investigated novel
4
molecule amplifiers
4

Similar Publications

A multi-component method for the synthesis of pyrimido[5,4-]azolo[1,5-]pyrimidines and pyrimido[4,5-][1,2,4]triazolo[5,1-][1,2,4]triazines has been developed. It was shown that vicinal amino-nitrile and amino-ethoxycarbonyl derivatives of azolo[1,5-]pyrimidines and azolo[5,1-][1,2,4]triazines were converted to tricyclic heterocycles in the "AcOH-RC(OEt)-amine" system. Reaction conditions were optimized, patterns of this process were investigated, and intermediates were isolated.

View Article and Find Full Text PDF

2-Chloropyridine-3-carbonitrile derivative was utilized as a key precursor to build a series of linear and angular annulated pyridines linked to a 6-hydroxy-4,7-dimethoxybenzofuran moiety. Reaction of substrate with various hydrazines afforded pyrazolo[3,4-]pyridines. Treatment of substrate with 1,3-,-binucleophiles including 3-amino-1,2,4-triazole, 5-amino-1-tetrazole, 3-amino-6-methyl-1,2,4-triazin-5(4)-one and 2-aminobenzimidazole produced the novel angular pyrido[3,2-][1,2,4]triazolo[4,3-]pyrimidine, pyrido[3,2-][1,2,4]tetrazolo[1,5-]pyrimidine, pyrido[3',2':5,6] pyrimido[2,1-][1,2,4]triazine and benzo[4,5]imidazo[1,2-]pyrido[3,2-]pyrimidine, respectively.

View Article and Find Full Text PDF

Pyrimido[4,5-b]indole derivatives bearing 1,2,4-oxadiazole moiety as MDM2 inhibitor candidates in cancer treatment.

Future Med Chem

March 2023

Isfahan Pharmaceutical Sciences Research Center & Department of Medicinal Chemistry, School of Pharmacy & Pharmaceutical Science, Isfahan University of Medical Sciences, Isfahan, 81746-73461, Iran.

In this study, novel hybrid structures of pyrimido-indole-oxadiazole were developed as MDM2 inhibitors for restoring the regular function of the p53. A multistep chemical pathway was used to synthesize the derivatives. Nutlin-3a was used as a standard lead in molecular docking and molecular dynamics simulations.

View Article and Find Full Text PDF

Bromodomain-containing protein 4 (BRD4) plays an extremely important physiological role in cancer, and the BRD4 inhibitors can effectively inhibit the proliferation of tumor cells. By taking BI-2536 (PLK1 and BRD4 inhibitor) as the lead compound, sixteen novel BRD4 inhibitors with the 4,4-difluoro-1-methyl-N,6-diphenyl-5,6-dihydro-4H-pyrimido[4,5-b] [1,2,4] triazolo[4,3-d] [1,4] diazepine-8-amine structure were designed and synthetized. Among the target compounds, compound 15h exhibited outstanding inhibition for BRD4-BD1 (IC value of 0.

View Article and Find Full Text PDF

Background: 2-amino-3-cyanopyridines are good starting reagents that have been used in synthesis of many heterocyclic compounds such as pyridopyrimidines, [1,2,4]triazolo and [1,2,3,4] tetrazolo derivatives which have biological activities as anti-microbial and cytotoxic activities. Meanwhile [1,2,4]triazolo and [1,2,3,4]tetrazolo derivatives are well known to possess many physiological activities, such as anticancer , antifungal, muscle relaxant, hypnotic, anti-inflammatory, diuretic and antihypertensive activities. A broad class of heterocyclic compounds has been studied to demonstrate their biological activity on the structures of DNA and RNA.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!